c-Myc (MYC) Human shRNA Plasmid Kit (Locus ID 4609)
CAT#: TF311323
MYC - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector, 5µg of each construct provided
Need custom shRNA service?
Get a free quote
CNY 4,790.00
货期*
现货
规格
Cited in 2 publications. |
Product images
经常一起买 (2)
c-Myc (c-Myc ) mouse monoclonal antibody, clone OTI1A6 (formerly 1A6)
CNY 1,999.00
CNY 2,700.00
Specifications
Product Data | |
Product Name | c-Myc (MYC) Human shRNA Plasmid Kit (Locus ID 4609) |
Locus ID | 4609 |
UniProt ID | P01106 |
Synonyms | bHLHe39; c-Myc; MRTL; MYCC |
Vector | pRFP-C-RS |
Format | Retroviral plasmids |
Kit Components | MYC - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector(Gene ID = 4609). 5µg purified plasmid DNA per construct29-mer scrambled shRNA cassette in pRFP-C-RS Vector, TR30015, included for free. |
RefSeq | NM_002467, NM_001354870, NM_002467.1, NM_002467.2, NM_002467.3, NM_002467.4, BC000141, BC000141.1, BC000917, BC058901, NM_002467.6 |
Summary | This gene is a proto-oncogene and encodes a nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. The encoded protein forms a heterodimer with the related transcription factor MAX. This complex binds to the E box DNA consensus sequence and regulates the transcription of specific target genes. Amplification of this gene is frequently observed in numerous human cancers. Translocations involving this gene are associated with Burkitt lymphoma and multiple myeloma in human patients. There is evidence to show that translation initiates both from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site, resulting in the production of two isoforms with distinct N-termini. [provided by RefSeq, Aug 2017] |
shRNA Design | These shRNA constructs were designed against multiple splice variants at this gene locus. To be certain that your variant of interest is targeted, please contact techsupport@origene.com. If you need a special design or shRNA sequence, please utilize our custom shRNA service. |
Performance Guaranteed | OriGene guarantees that the sequences in the shRNA expression cassettes are verified to correspond to the target gene with 100% identity. One of the four constructs at minimum are guaranteed to produce 70% or more gene expression knock-down provided a minimum transfection efficiency of 80% is achieved. Western Blot data is recommended over qPCR to evaluate the silencing effect of the shRNA constructs 72 hrs post transfection. To properly assess knockdown, the gene expression level from the included scramble control vector must be used in comparison with the target-specific shRNA transfected samples. For non-conforming shRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the shRNA kit. To arrange for a free replacement with newly designed constructs, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled shRNA control (Western Blot data preferred). |
Citations (2)
The use of this RNAi has been cited in the following citations: |
---|
The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma
,Hayashi, A;Fan, J;Chen, R;Makohon-Moore, AP;,
bioRxiv
[MYC]
|
c-Myc Dependent Cell Competition in Human Cancer Cells
,Patel, MS;Shah, HS;Shrivastava, N;,
J. Cell. Biochem
,PubMed ID 27982483
[MYC]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...